Literature DB >> 8557670

Lipoyl domain-based mechanism for the integrated feedback control of the pyruvate dehydrogenase complex by enhancement of pyruvate dehydrogenase kinase activity.

S Ravindran1, G A Radke, J R Guest, T E Roche.   

Abstract

To conserve carbohydrate reserves, the reaction of the pyruvate dehydrogenase complex (PDC) must be down-regulated when the citric acid cycle is provided sufficient acetyl-CoA. PDC activity is reduced primarily through increased phosphorylation of its pyruvate dehydrogenase (E1) component due to E1 kinase activity being markedly enhanced by elevated intramitochondrial NADH:NAD+ and acetyl-CoA:CoA ratios. A mechanism is evaluated in which enhanced kinase activity is facilitated by the build-up of the reduced and acetylated forms of the lipoyl moieties of the dihydrolipoyl acetyltransferase (E2) component through using NADH and acetyl-CoA in the reverse of the downstream reactions of the complex. Using a peptide substrate, kinase activity was stimulated by these products, ruling out the possibility kinase activity is increased due to changes in the reaction state of its substrate, E1 (thiamin pyrophosphate). Each E2 subunit contains two lipoyl domains, an NH2-terminal (L1) and the inward lipoyl domain (L2), which were individually produced in fully lipoylated forms by recombinant techniques. Although reduction and acetylation of the L1 domain or free lipoamide increased kinase activity, those modifications of the lipoate of the kinase-binding L2 domain gave much greater enhancements of kinase activity. The large stimulation of the kinase generated by acetyl-CoA only occurred upon addition of the transacetylase-catalyzing (lipoyl domain-free) inner core portion of E2 plus a reduced lipoate source, affirming that acetylation of this prosthetic group is an essential mechanistic step for acetyl-CoA enhancing kinase activity. Similarly, the lesser stimulation of kinase activity by just NADH required a lipoate source, supporting the need for lipoate reduction by E3 catalysis. Complete enzymatic delipoylation of PDC, the E2-kinase subcomplex, or recombinant L2 abolished the stimulatory effects of NADH and acetyl-CoA. Retention of a small portion of PDC lipoates lowered kinase activity but allowed stimulation of this residual kinase activity by these products. Reintroduction of lipoyl moieties, using lipoyl protein ligase, restored the capacity of the E2 core to support high kinase activity along with stimulation of that activity up to 3-fold by NADH and acetyl-CoA. As suggested by those results, the enhancement of kinase activity is very responsive to reductive acetylation with a half-maximal stimulation achieved with approximately 20% of free L2 acetylated and, from an analysis of previous results, with acetylation of only 3-6 of the 60 L2 domains in intact PDC. Based on these findings, we suggest that kinase stimulation results from modification of the lipoate of an L2 domain that becomes specifically engaged in binding the kinase. In conclusion, kinase activity is attenuated through a substantial range in response to modest changes in the proportion of oxidized, reduced, and acetylated lipoyl moieties of the L2 domain of E2 produced by fluctuations in the NADH:NAD+ and acetyl-CoA:CoA ratios as translated by the rapid and reversible E3 and E2 reactions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8557670     DOI: 10.1074/jbc.271.2.653

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Structure of pyruvate dehydrogenase kinase. Novel folding pattern for a serine protein kinase.

Authors:  C N Steussy; K M Popov; M M Bowker-Kinley; R B Sloan; R A Harris; J A Hamilton
Journal:  J Biol Chem       Date:  2001-08-01       Impact factor: 5.157

2.  Effects of aerobic training on pyruvate dehydrogenase and pyruvate dehydrogenase kinase in human skeletal muscle.

Authors:  Paul J LeBlanc; Sandra J Peters; Rebecca J Tunstall; David Cameron-Smith; George J F Heigenhauser
Journal:  J Physiol       Date:  2004-03-12       Impact factor: 5.182

3.  Crystal structure of an asymmetric complex of pyruvate dehydrogenase kinase 3 with lipoyl domain 2 and its biological implications.

Authors:  Yancho Devedjiev; C Nicklaus Steussy; Dmitry G Vassylyev
Journal:  J Mol Biol       Date:  2007-05-10       Impact factor: 5.469

4.  Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex.

Authors:  M M Bowker-Kinley; W I Davis; P Wu; R A Harris; K M Popov
Journal:  Biochem J       Date:  1998-01-01       Impact factor: 3.857

5.  The carboxy-terminal tail of pyruvate dehydrogenase kinase 2 is required for the kinase activity.

Authors:  Alla Klyuyeva; Alina Tuganova; Kirill M Popov
Journal:  Biochemistry       Date:  2005-10-18       Impact factor: 3.162

6.  Nematode pyruvate dehydrogenase kinases: role of the C-terminus in binding to the dihydrolipoyl transacetylase core of the pyruvate dehydrogenase complex.

Authors:  W Chen; P R Komuniecki; R Komuniecki
Journal:  Biochem J       Date:  1999-04-01       Impact factor: 3.857

7.  5'-AMP activated protein kinase α2 controls substrate metabolism during post-exercise recovery via regulation of pyruvate dehydrogenase kinase 4.

Authors:  Andreas Maechel Fritzen; Anne-Marie Lundsgaard; Jacob Jeppesen; Mette Landau Brabaek Christiansen; Rasmus Biensø; Jason R B Dyck; Henriette Pilegaard; Bente Kiens
Journal:  J Physiol       Date:  2015-11-01       Impact factor: 5.182

8.  Role of pyruvate dehydrogenase kinase 4 in regulation of blood glucose levels.

Authors:  Nam Ho Jeoung; Robert A Harris
Journal:  Korean Diabetes J       Date:  2010-10-31

9.  Starvation and diabetes reduce the amount of pyruvate dehydrogenase phosphatase in rat heart and kidney.

Authors:  Boli Huang; Pengfei Wu; Kirill M Popov; Robert A Harris
Journal:  Diabetes       Date:  2003-06       Impact factor: 9.461

10.  Long-term prediction of fish growth under varying ambient temperature using a multiscale dynamic model.

Authors:  Nadav S Bar; Nicole Radde
Journal:  BMC Syst Biol       Date:  2009-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.